274 related articles for article (PubMed ID: 15497779)
21. Organization and operation of a flow cytometric immunophenotyping laboratory.
Foucar K; Chen IM; Crago S
Semin Diagn Pathol; 1989 Feb; 6(1):13-36. PubMed ID: 2919238
[TBL] [Abstract][Full Text] [Related]
22. Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
Dalal BI
J Assoc Physicians India; 2007 Aug; 55():571-3. PubMed ID: 18019799
[TBL] [Abstract][Full Text] [Related]
23. Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies.
Ruiz-Argüelles A; Rivadeneyra-Espinoza L; Duque RE; Orfao A;
Cytometry B Clin Cytom; 2006 Jan; 70(1):39-44. PubMed ID: 16353215
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotyping of leukaemias by flow cytometry and APAAP: a two-year comparative analysis in hospital practice.
Sewell HF; Milton JI; MacKenzie R; King DJ; Dawson AA; Lessels SE; Bennett B; Davidson RL; Walker F
Dis Markers; 1988; 6(4):221-9. PubMed ID: 3069283
[TBL] [Abstract][Full Text] [Related]
25. Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer.
Björnsson S; Wahlström S; Norström E; Bernevi I; O'Neill U; Johansson E; Runström H; Simonsson P
Cytometry B Clin Cytom; 2008 Mar; 74(2):91-103. PubMed ID: 18061952
[TBL] [Abstract][Full Text] [Related]
26. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications.
Davis BH; Holden JT; Bene MC; Borowitz MJ; Braylan RC; Cornfield D; Gorczyca W; Lee R; Maiese R; Orfao A; Wells D; Wood BL; Stetler-Stevenson M
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S5-13. PubMed ID: 17803188
[TBL] [Abstract][Full Text] [Related]
27. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence intensity of immunostained cells as a diagnostic aid in lymphoid leukemias.
Caldwell CW; Patterson WP
Diagn Clin Immunol; 1988; 5(6):371-6. PubMed ID: 3265361
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotyping of lymphoproliferative disorders: state of the art.
Gudgin EJ; Erber WN
Pathology; 2005 Dec; 37(6):457-78. PubMed ID: 16373227
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic value of flow cytometric immunophenotyping in malignant hematological diseases.
Chianese R; Brando B; Gratama JW;
J Biol Regul Homeost Agents; 2002; 16(4):259-69. PubMed ID: 12597642
[TBL] [Abstract][Full Text] [Related]
31. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
32. Recipient-derived cells after cord blood transplantation: dynamics elucidated by multicolor FACS, reflecting graft failure and relapse.
Watanabe N; Takahashi S; Ishige M; Ishii Y; Ooi J; Tomonari A; Tsukada N; Konuma T; Kato S; Sato A; Tojo A; Nakauchi H
Biol Blood Marrow Transplant; 2008 Jun; 14(6):693-701. PubMed ID: 18489995
[TBL] [Abstract][Full Text] [Related]
33. Three-color flowcytometric analysis of mature and immature hematological malignancies. A guideline of the Dutch Foundation for Immunophenotyping of Hematological Malignancies (SIHON).
van Wering ER; van Lochem EG; Leenders M; van der Sluijs-Gelling AJ; Wind H; Gratama JW; Kraan J; Preijers FW
J Biol Regul Homeost Agents; 2004; 18(3-4):313-26. PubMed ID: 15786698
[TBL] [Abstract][Full Text] [Related]
34. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.
Orfao A; Schmitz G; Brando B; Ruiz-Arguelles A; Basso G; Braylan R; Rothe G; Lacombe F; Lanza F; Papa S; Lucio P; San Miguel JF
Clin Chem; 1999 Oct; 45(10):1708-17. PubMed ID: 10508115
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
36. Immunophenotyping of hematopoietic neoplasms.
Chu PG; Chang KL; Arber DA; Weiss LM
Semin Diagn Pathol; 2000 Aug; 17(3):236-56. PubMed ID: 10968709
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotyping leukemias: the new force in hematology.
Sullivan JG; Wiggers TB
Clin Lab Sci; 2000; 13(2):117-22. PubMed ID: 11066450
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies: new diagnostic and therapeutic means in acute leukaemias.
Schranz V
Ther Hung; 1990; 38(1):3-12. PubMed ID: 2189232
[TBL] [Abstract][Full Text] [Related]
39. The role of flow cytometric immunophenotyping in myelodysplastic syndromes.
Pagnucco G; Giambanco C; Gervasi F
Ann N Y Acad Sci; 2006 Nov; 1089():383-94. PubMed ID: 17261782
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
